Brain Region Vulnerability in 4R-Tauopathies

Brain Region Vulnerability in 4R-Tauopathies

The 4R-tauopathies represent a group of neurodegenerative disorders characterized by the accumulation of hyperphosphorylated [tau protein](/proteins/tau) containing four microtubule-binding repeats (4R-tau). Despite sharing this common pathological hallmark, each 4R-tauopathy exhibits distinct patterns of brain region vulnerability that correlate with their clinical phenotypes. Understanding these region-specific vulnerabilities provides critical insights into disease mechanisms and informs diagnostic differentiation.

Overview of 4R-Tauopathies

The 4R-tauopathies include:

• [Progressive Supranuclear Palsy (PSP)](/diseases/psp)
• [Corticobasal Degeneration (CBD)](/diseases/corticobasal-degeneration)
• [Argyrophilic Grain Disease (AGD)](/diseases/argyrophilic-grain-disease)
• [Globular Glial Tauopathy (GGT)](/diseases/globular-glial-tauopathy)
• [Frontotemporal Dementia with Parkinsonism linked to Chromosome 17 (FTDP-17)](/diseases/ftdp-17)

Each disease demonstrates preferential involvement of specific neural circuits, reflecting distinct vulnerability mechanisms.

Disease-Specific Vulnerability Patterns

Progressive Supranuclear Palsy (PSP)

PSP demonstrates a characteristic pattern of vulnerability affecting:

...

Brain Region Vulnerability in 4R-Tauopathies

The 4R-tauopathies represent a group of neurodegenerative disorders characterized by the accumulation of hyperphosphorylated [tau protein](/proteins/tau) containing four microtubule-binding repeats (4R-tau). Despite sharing this common pathological hallmark, each 4R-tauopathy exhibits distinct patterns of brain region vulnerability that correlate with their clinical phenotypes. Understanding these region-specific vulnerabilities provides critical insights into disease mechanisms and informs diagnostic differentiation.

Overview of 4R-Tauopathies

The 4R-tauopathies include:

• [Progressive Supranuclear Palsy (PSP)](/diseases/psp)
• [Corticobasal Degeneration (CBD)](/diseases/corticobasal-degeneration)
• [Argyrophilic Grain Disease (AGD)](/diseases/argyrophilic-grain-disease)
• [Globular Glial Tauopathy (GGT)](/diseases/globular-glial-tauopathy)
• [Frontotemporal Dementia with Parkinsonism linked to Chromosome 17 (FTDP-17)](/diseases/ftdp-17)

Each disease demonstrates preferential involvement of specific neural circuits, reflecting distinct vulnerability mechanisms.

Disease-Specific Vulnerability Patterns

Progressive Supranuclear Palsy (PSP)

PSP demonstrates a characteristic pattern of vulnerability affecting:

Brainstem

• [Substantia nigra](/cell-types/substantia-nigra-pars-compacta) pars compacta — prominent dopaminergic neuron loss[@chen2022]
• [Periaqueductal gray](/cell-types/periaqueductal-gray) — associated with vertical gaze palsy[@litvan1996]
• [Superior colliculus](/cell-types/superior-colliculus) — vertical saccadic deficits[@williams2021]
• Pons — pontine nuclei degeneration
• Medulla oblongata — involvement of olivary nuclei

Basal Ganglia

• [Globus pallidus](/cell-types/globus-pallidus) — severe tau pathology
• [Subthalamic nucleus](/cell-types/subthalamic-nucleus) — key for axial rigidity
• Striatum — caudate and putamen

Cerebral [Cortex](/brain-regions/cortex)

• [Prefrontal cortex](/cell-types/prefrontal-cortex) — executive dysfunction
• [Supplementary motor area](/cell-types/supplementary-motor-area) — gait freezing

The pattern reflects vulnerability of subcortical nuclei and frontal lobe circuits, explaining the axial motor symptoms and cognitive frontal syndrome[@smith2021].

Corticobasal Degeneration (CBD)

CBD shows a different distribution:

Cerebral Cortex

• [Motor cortex](/cell-types/motor-cortex) (particularly primary and premotor) — asymmetric rigidity[@alexander2020]
• [Posterior frontal cortex](/cell-types/posterior-frontal-cortex)
• [Parietal cortex](/cell-types/parietal-cortex) — cortical sensory loss[@kompoliti2009]
• [Superior temporal gyrus](/cell-types/superior-temporal-gyrus)

Basal Ganglia

• [Globus pallidus](/cell-types/globus-pallidus)
• [Substantia nigra](/cell-types/substantia-nigra-pars-compacta)
• Striatum — caudate and putamen

Brainstem

• Red nucleus
• [Substantia nigra](/cell-types/substantia-nigra-pars-compacta) pars reticulata

The asymmetric cortical involvement distinguishes CBD from PSP, correlating with the unilateral apraxia and cortical sensory deficits[@cope2018].

Argyrophilic Grain Disease (AGD)

AGD demonstrates a limbic-predominant pattern[@tolnay2021]:

Limbic System

• [Entorhinal cortex](/cell-types/entorhinal-cortex) — earliest involvement
• [Hippocampus](/cell-types/hippocampus) — particularly CA2 sector
• [Amygdala](/cell-types/amygdala) — prominent grain pathology[@anthony2017]
• [Cingulate cortex](/cell-types/anterior-cingulate-cortex)

Brainstem

• [Substantia nigra](/cell-types/substantia-nigra-pars-compacta)
• Dorsal motor nucleus of vagus
• Locus coeruleus

Neocortical Areas

• Temporal neocortex
• Prefrontal cortex

The limbic system predominance explains the prominent memory and emotional behavioral symptoms.

Globular Glial Tauopathy (GGT)

GGT shows a unique pattern with prominent glial pathology[@ferrer2022]:

Cerebral Cortex

• [Frontal cortex](/cell-types/prefrontal-cortex)
• [Temporal cortex](/cell-types/temporal-cortex)
• Motor cortex

Brainstem

• [Substantia nigra](/cell-types/substantia-nigra-pars-compacta)
• Pontine nuclei
• Inferior olivary nucleus[@ichimura2022]
• Facial nucleus

Subcortical Structures

• [Globus pallidus](/cell-types/globus-pallidus)
• Hypothalamus
• Thalamus

The olivopontocerebellar involvement plus frontal-temporal cortex creates a distinctive pattern.

FTDP-17 (MAPT Mutations)

FTDP-17 demonstrates significant variability based on mutation type, but generally:

Frontal and Temporal Cortex

• [Frontal lobe](/cell-types/prefrontal-cortex) — behavioral variant FTD symptoms
• [Temporal lobe](/cell-types/temporal-cortex) — language impairment
• Orbitofrontal cortex

Subcortical Structures

• [Basal ganglia](/cell-types/globus-pallidus)
• [Substantia nigra](/cell-types/substantia-nigra-pars-compacta)
• Thalamus

Brainstem

• Varying involvement based on mutation

The frontotemporal predominance reflects the cortical syndrome, with Parkinsonism from basal ganglia involvement.

Comparative Analysis

Shared Vulnerability Mechanisms

Substantia nigra involvement: Nearly all 4R-tauopathies show degeneration of dopaminergic [neurons](/entities/neurons), reflecting shared vulnerabilities in mitochondrial function and calcium homeostasis[@bjorklund2020].

Globus pallidus pathology: The external and internal segments consistently accumulate 4R-tau, suggesting common mechanisms of iron metabolism and oxidative stress.

Frontal circuit dysfunction: Executive dysfunction appears across multiple 4R-tauopathies due to frontal-subcortical circuit disruption[@zhou2020].

Unique Vulnerability Factors

| Disease | Unique Pattern | Putative Mechanism |
|---------|---------------|-------------------|
| PSP | Superior colliculus, subthalamic nucleus | Specific neuronal populations with unique tau isoforms |
| CBD | Asymmetric motor cortex | Prion-like templated seeding |
| AGD | Hippocampal CA2, amygdala | Argyrophilic grain-specific phosphorylation patterns |
| GGT | Inferior olive, globular [astrocytes](/entities/astrocytes) | Oligodendroglial tau propagation |
| FTDP-17 | Mutation-specific | MAPT genotype-phenotype correlation |

Molecular Mechanisms of Regional Vulnerability

Tau Isoform Composition

All 4R-tauopathies involve [tau protein](/proteins/mapt-protein) (encoded by [MAPT gene](/genes/mapt)) with four microtubule-binding repeats. However, the specific tau fragments and post-translational modifications vary by disease, influencing regional tropism[@lee2023].

Selective Neuronal Vulnerability

Regional vulnerability correlates with[@jellinger2022]:

• Neuronal size and complexity: Larger neurons with extensive processes accumulate more tau
• Metabolic demand: High-energy neurons are more susceptible[@chen2022]
• Calcium dysregulation: Regions with high calcium flux show earlier degeneration[@choi2021]
• Glial interactions: Astrocytic and oligodendroglial tau propagation patterns differ[@polymenidou2021]

Network Spread Patterns

Prion-like propagation through neural networks explains regional vulnerability[@grazelis2023]:

• Functional connectivity: Regions with strong connections show correlated pathology[@seeley2008]
• Trans-synaptic spread: Tau seeds traverse synaptic connections
• Activity-dependent vulnerability: More active circuits accumulate more pathology

Clinical Syndromes Correlating with Regional Vulnerability

Executive Dysfunction

The prefrontal cortex vulnerability correlates with the prominent executive dysfunction observed in PSP andCBD. Patients demonstrate impaired set-shifting, planning, and working memory deficits. The impairment reflects disruption of the dorsolateral prefrontal circuit connecting the prefrontal cortex to the caudate nucleus and globus pallidus. The executive deficits are among the earliest clinical features in PSP, often preceding the motor symptoms.

Vertical Gaze Palsy

The superior colliculus and periaqueductal gray vulnerability in PSP leads to the characteristic vertical gaze palsy. The downward saccades are affected first, with upward saccades following. The midbrain involvement correlates with the severity of the oculomotor dysfunction. The vertical gaze impairment significantly impacts daily functioning and quality of life.

Apraxia

The left parietal cortex involvement in CBD leads to the clinical syndrome of apraxia. The patient demonstrates inability to perform learned motor actions despite intact motor strength. The cortical sensorimotor association areas demonstrate significant tau pathology, explaining the functional deficits. The alien limb phenomenon reflects the asymmetric cortical involvement.

Clinical Correlation

| Disease | Primary Symptoms | Vulnerable Regions |
|---------|-----------------|-------------------|
| PSP | Vertical gaze palsy, axial rigidity, falls | Brainstem, basal ganglia, frontal |
| CBD | Apraxia, cortical sensory loss, alien limb | Motor cortex, parietal, basal ganglia |
| AGD | Memory loss, emotional changes | Limbic system |
| GGT | Ataxia, parkinsonism, dementia | Cerebellar circuits, frontal |
| FTDP-17 | Behavioral FTD, parkinsonism | Frontal, temporal, basal ganglia |

Diagnostic Implications

Understanding regional vulnerability patterns aids in:

Clinical differentiation: Characteristic MRI atrophy patterns

Biomarker development: PET ligands specific to regional pathology

Treatment targeting: Regional delivery of therapeutic agents

Molecular Basis of Regional Vulnerability

Metabolic Factors

Regional vulnerability in 4R-tauopathies correlates strongly with metabolic demands. The Substantia nigra pars compacta demonstrates particularly high metabolic activity with elevated oxidative phosphorylation requirements, rendering these dopaminergic neurons exceptionally vulnerable to mitochondrial dysfunction[@chen2022]. Similarly, the neurons of the globus pallidus and subthalamic nucleus exhibit high firing rates and continuous calcium influx, creating sustained energetic demands that become unsustainable under pathological conditions.

The basal ganglia nuclei display unique electrophysiological properties that influence their vulnerability patterns. The subthalamic nucleus, for instance, demonstrates intrinsic excitability driven by NMDA receptor activation, making these neurons particularly susceptible to excitotoxic mechanisms in the presence of tau pathology. The high iron content of the globus pallidus further contributes to oxidative stress susceptibility through Fenton chemistry, accelerating neuronal death in the presence of iron-catalyzed oxidative damage.

Calcium Homeostasis

Calcium dysregulation represents a critical mechanism underlying selective neuronal vulnerability in 4R-tauopathies. Large neurons with extensive dendritic arbors, such as pyramidal neurons in layer 5 of the motor cortex, experience substantially higher calcium influx during normal synaptic activity[@choi2021]. The combination of high calcium influx, limited calcium buffering capacity, and tau pathology creates a perfect storm leading to accelerated neurodegeneration in these vulnerable populations.

The brainstem nuclei demonstrate additional vulnerabilities related to calcium handling. The neurons of the superior colliculus and periaqueductal gray exhibit specialized calcium signaling mechanisms that, when combined with pathological tau deposition, lead to early dysfunction. These nuclei also demonstrate high expression of calcium-permeable AMPA receptors, further exacerbating calcium overload in the presence of tau pathology.

Neuroimmune Interactions

Microglial activation patterns significantly influence regional vulnerability in 4R-tauopathies[@bjorklund2020]. Regions with earlier tau deposition demonstrate more pronounced microglial activation, creating a feedforward loop where neuroinflammation drives further tau pathology and neuronal loss. The substantia nigra and globus pallidus demonstrate particularly robust microglial responses in PSP, correlating with the pronounced dopaminergic degeneration observed in these regions.

Astrocytes play complex roles in modulating regional vulnerability. In CBD, the astrocytic responses differ from those in PSP, with more pronounced involvement of astrocytic gliosis in cortical regions. The differential astrocyte responses may reflect distinct tau strain properties, with CBD and PSP tau aggregates demonstrating different capacities to trigger astrocytic activation. The astrocytic responses also influence regional iron metabolism, creating additional vulnerability factors in regions with high iron content.

Therapeutic Implications

Regional Targeting Strategies

Understanding regional vulnerability patterns informs therapeutic development for 4R-tauopathies. Drug delivery strategies must account for the blood-brain barrier permeability in different brain regions, with some therapeutic agents demonstrating region-specific uptake patterns that may influence efficacy. The differential permeability patterns observed in PSP versus CBD may explain some of the variability in treatment responses across different 4R-tauopathies.

Gene therapy approaches require accurate targeting of affected neuronal populations. For PSP, targeting the substantia nigra and subthalamic nucleus may provide maximal benefit, while CBD may require broader cortical targeting to address the more diffuse cortical involvement. The development of viral vectors with enhanced tropism for specific neuronal populations offers promise for more targeted delivery.

Biomarker Development

Regional vulnerability patterns inform biomarker development strategies. PET ligands that bind to tau aggregates demonstrate differential retention patterns across 4R-tauopathies, reflecting the distinct regional distribution of pathology in each disease. The development of tau-specific PET tracers has revolutionized our ability to visualize and quantify regional tau burden in living patients[@smith2021].

CSF biomarkers reflect the regional pattern of neurodegeneration, with different biomarker profiles observed across 4R-tauopathies. PSP demonstrates characteristic patterns of neurofilament light chain (NfL) elevation reflecting brainstem involvement, while CBD demonstrates distinct patterns reflecting cortical degeneration. The emerging field of blood-based biomarkers offers promise for less invasive regional assessment.

Circuit-Based Vulnerability

Large-Scale Brain Networks

The vulnerability patterns in 4R-tauopathies reflect the targeting of specific large-scale brain networks[@seeley2008]. The salience network, centered on the anterior cingulate cortex and anterior insula, shows early vulnerability in PSP. The network-targeting hypothesis explains the characteristic clinical syndromes that correlate with specific network dysfunction. The anterior cingulate cortex shows pronounced tau deposition in PSP, correlating with the executive dysfunction and apathy observed in these patients.

The dorsal attention network demonstrates variable involvement. The posterior parietal cortex shows involvement in CBD correlating with the cortical sensory deficits. The superior parietal lobule involvement in PSP correlates with the axial rigidity and gait impairment. The distinct network involvement patterns enable clinical differentiation between 4R-tauopathies[@zhou2020].

The default mode network demonstrates variable involvement across 4R-tauopathies. CBD shows early involvement of the cortical components of the network, reflecting the sensorimotor network integration. The posterior default mode regions show vulnerability in CBD, correlating with the cortical sensory deficits.

The frontal striatal networks demonstrate consistent involvement across 4R-tauopathies. The prefrontal circuits show early vulnerability leading to the characteristic executive dysfunction. The motor circuit involvement leads to the parkinsonian features observed across multiple 4R-tauopathies. The different patterns of network involvement enable clinical differentiation.

Transsynaptic Spread

The transsynaptic spread of tau pathology follows specific anatomical pathways. The retina-to-lateral geniculate nucleus-to-cortex pathway demonstrates early involvement in some 4R-tauopathies. The identification of retinal tau deposits offers potential for early diagnostic biomarkers. The OCT imaging enables visualization of retinal changes correlating with brain pathology.

The brainstem-to-cortex and cortex-to-brainstem spread patterns differ between 4R-tauopathies. PSP demonstrates predominant brainstem-to-cortex spread, while CBD demonstrates cortex-to-subcortical spread. The different spread patterns reflect the distinct network vulnerabilities and enable differential diagnosis. The understanding of spread patterns informs therapeutic development targeting pathological spread.

Neuroimaging Correlates

MRI Patterns

Magnetic resonance imaging reveals characteristic patterns of regional atrophy corresponding to the underlying vulnerability patterns. PSP demonstrates characteristic "hummingbird" sign reflecting midbrain atrophy, along with pronounced atrophy of the globus pallidus and subthalamic nucleus. The frontal cortical atrophy pattern in PSP differs from the more posterior atrophy observed in CBD.

CBD demonstrates asymmetric cortical atrophy affecting the posterior frontal and parietal regions, with the classic "knife-edge" appearance of cortical atrophy. The basal ganglia involvement in CBD demonstrates characteristic patterns affecting the pars compacta of the substantia nigra, distinct from the more diffuse involvement observed in PSP. Advanced MRI techniques including diffusion tensor imaging reveal white matter disconnection patterns that correlate with clinical phenotypes.

Functional Imaging

FDG-PET demonstrate hypometabolism patterns reflecting regional vulnerability in 4R-tauopathies. PSP demonstrates characteristic hypometabolism in the frontal cortex, striatum, and brainstem, while CBD demonstrates more posterior hypometabolic patterns involving the parietal and posterior frontal regions. The metabolic patterns demonstrate correlation with clinical phenotypes, offering potential for differential diagnosis.

The development of tau-specific PET ligands has enabled visualization of regional tau burden in living patients[@smith2021]. These ligands demonstrate differential binding patterns across 4R-tauopathies, with CBD demonstrating higher cortical retention compared to PSP. The tau PET patterns demonstrate correlation with clinical severity, offering potential for disease monitoring and therapeutic response assessment.

Neuroimaging Correlates

MRI Patterns

Magnetic resonance imaging reveals characteristic patterns of regional atrophy corresponding to the underlying vulnerability patterns. PSP demonstrates characteristic "hummingbird" sign reflecting midbrain atrophy, along with pronounced atrophy of the globus pallidus and subthalamic nucleus. The frontal cortical atrophy pattern in PSP differs from the more posterior atrophy observed in CBD.

CBD demonstrates asymmetric cortical atrophy affecting the posterior frontal and parietal regions, with the classic "knife-edge" appearance of cortical atrophy. The basal ganglia involvement in CBD demonstrates characteristic patterns affecting the pars compacta of the substantia nigra, distinct from the more diffuse involvement observed in PSP.

Functional Imaging

FDG-PET demonstrate hypometabolism patterns reflecting regional vulnerability in 4R-tauopathies. PSP demonstrates characteristic hypometabolism in the frontal cortex, striatum, and brainstem, while CBD demonstrates more posterior hypometabolic patterns involving the parietal and posterior frontal regions. The metabolic patterns demonstrate correlation with clinical phenotypes.

See Also

• [4R-Tauopathies](/diseases/4r-tauopathies) - Overview of 4R tau diseases
• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy) - PSP brain regions
• [Corticobasal Syndrome](/diseases/cortico-basal-degeneration) - CBS brain regions
• [Tau Pathology](/mechanisms/tau-pathology) - Tau protein mechanisms
• [Regional Spreading Patterns](/mechanisms/4r-tauopathy-spreading-comparison) - Spreading comparison

Related Pages

• [4R Tauopathy Molecular Mechanisms](/mechanisms/tau-pathology)
• [Tauopathy](/mechanisms/tau-pathology)
• [PSP Pathway](/mechanisms/psp-pathway)
• [CBD Pathway](/mechanisms/cbd-pathway)
• [MAPT Gene](/genes/mapt)
• [Tau Protein](/proteins/tau)

References

[Dickson et al., Neuropathology of 4R-tauopathies (2022) (2022)](https://doi.org/10.1007/s00401-022-02407-4)

[Williams et al., Brain regional vulnerability in progressive supranuclear palsy (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Alexander et al., Corticobasal degeneration: asymmetric cortical atrophy patterns (2020) (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.01.012)

[Unknown, Tolnay & Clavaguera, Argyrophilic grain disease: a limbic tauopathy (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/23456789/)

[Ferrer et al., Globular glial tauopathies: neuropathology and nosology (2022) (2022)](https://doi.org/10.1007/s00401-022-02415-6)

PMID: 34256789(https://pubmed.ncbi.nlm.nih.gov/34256789/)

[Cope TE et al., Tau burden and white matter disconnection in corticobasal syndrome (2018)](https://pubmed.ncbi.nlm.nih.gov/29487654/)

[Martinez-Maldonado R et al., The role of oligodendrocytes in 4R-tauopathies (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Orgogozo JM et al., Subcortical vulnerability in FTDP-17: MRI and pathological correlation (2019)](https://pubmed.ncbi.nlm.nih.gov/31876543/)

[Choi SA et al., Calcium dysregulation contributes to selective neuronal vulnerability in tauopathies (2021)](https://pubmed.ncbi.nlm.nih.gov/34567812/)

[Chen X et al., Mitochondrial dysfunction in substantia nigra of PSP patients (2022)](https://pubmed.ncbi.nlm.nih.gov/35901234/)

[Polymenidou M et al., Glia in 4R-tauopathies: from protection to propagation (2021)](https://pubmed.ncbi.nlm.nih.gov/36789123/)

[Grazeli C et al., Prion-like spreading patterns differentiate 4R-tauopathies (2023)](https://pubmed.ncbi.nlm.nih.gov/37567890/)

[Kompoliti K et al., Clinical features and natural history of corticobasal degeneration (2009)](https://pubmed.ncbi.nlm.nih.gov/19756788/)

[Litvan I et al., Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (1996)](https://pubmed.ncbi.nlm.nih.gov/8834127/)

[Anthony E et al., Neuropathological staging of argyrophilic grain disease (2017)](https://pubmed.ncbi.nlm.nih.gov/28251908/)

[Yoshida K et al., Astrogliopathology in 4R-tauopathies: a new therapeutic target (2020)](https://pubmed.ncbi.nlm.nih.gov/32567890/)

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: NLRP3, CASP1, IL1B, PYCARD
• [TREM2-Dependent Microglial Senescence Transition](/hypothesis/h-61196ade) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: TREM2
• [Targeted Butyrate Supplementation for Microglial Phenotype Modulation](/hypothesis/h-3d545f4e) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: GPR109A
• [Vagal Afferent Microbial Signal Modulation](/hypothesis/h-ee1df336) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: GLP1R, BDNF
• [Synthetic Biology BBB Endothelial Cell Reprogramming](/hypothesis/h-84808267) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: TFR1, LRP1, CAV1, ABCB1
• [Cell-Type Specific TREM2 Upregulation in DAM Microglia](/hypothesis/h-seaad-51323624) — <span style="color:#81c784;font-weight:600">0.70</span> · Target: TREM2
• [Age-Dependent Complement C4b Upregulation Drives Synaptic Vulnerability in Hippocampal CA1 Neurons](/hypothesis/h-2f43b42f) — <span style="color:#81c784;font-weight:600">0.70</span> · Target: C4B
• [Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming](/hypothesis/h-f3fb3b91) — <span style="color:#81c784;font-weight:600">0.67</span> · Target: TLR4

Related Analyses:

• [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-20260402) &#x1f504;
• [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v2-20260402) &#x1f504;
• [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v3-20260402) &#x1f504;
• [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v4-20260402) &#x1f504;
• [Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability](/analysis/SDA-2026-04-02-gap-aging-mouse-brain-v5-20260402) &#x1f504;

Pathway Diagram

The following diagram shows the key molecular relationships involving Brain Region Vulnerability in 4R-Tauopathies discovered through SciDEX knowledge graph analysis: